Thomas Andersson
Corporate Officer/Principal chez KAROLINSKA DEVELOPMENT AB
Profil
Thomas B.
Andersson is currently a Director at Skogsmöllan AB, Kongsberg Beam Technology AS, and Investment Manager at Karolinska Development AB.
He was previously the Chief Executive Officer at SpectraCure AB, Annexin Pharmaceuticals AB, and Lund University Bioscience AB from 2007 to 2012.
He was also the Chairman at ProNoxis AB and Director at DermaGen AB.
Dr. Andersson holds a graduate and doctorate degree from the University of Lund.
Postes actifs de Thomas Andersson
| Sociétés | Poste | Début |
|---|---|---|
| KAROLINSKA DEVELOPMENT AB | Corporate Officer/Principal | - |
Kongsberg Beam Technology AS
 Kongsberg Beam Technology AS Miscellaneous Commercial ServicesCommercial Services Kongsberg Beam Technology AS develops and provides solutions for precise therapeutic radiation. The company was founded on August 2, 2005 and is headquartered in Kongsberg, Norway. | Directeur/Membre du Conseil | - |
Skogsmöllan AB
 Skogsmöllan AB Pharmaceuticals: MajorHealth Technology Skogsmöllan AB is a private company based in Veberod, Sweden. The Swedish company provides pharmaceutical preparation services. | Directeur/Membre du Conseil | - |
Anciens postes connus de Thomas Andersson
| Sociétés | Poste | Fin |
|---|---|---|
| ISOFOL MEDICAL AB | Directeur Général | 21/06/2023 |
Lund University Bioscience AB
 Lund University Bioscience AB Investment ManagersFinance Lund University Bioscience AB (LU Bio) is an investment firm located in Lund, Sweden. In May 2007, LU Bio was founded by the parent firm, Lund University Development AB. They specialize in early-stage investments within the life sciences segment. Lund University was founded by the Swedish government in 1666. The university has three main research areas: medicine and pharmaceuticals, globally sustainable societal development, and the life sciences. | Directeur Général | 31/12/2012 |
| ANNEXIN PHARMACEUTICALS AB | Directeur Général | - |
| SPECTRACURE AB | Directeur Général | - |
ProNoxis AB
 ProNoxis AB Pharmaceuticals: MajorHealth Technology ProNoxis AB develops small-molecule drugs to treat chronic inflammation. The company was founded in 2009 and is headquartered in Lund, Sweden. | Président | - |
Formation de Thomas Andersson
| University of Lund | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| SPECTRACURE AB | Electronic Technology |
| ISOFOL MEDICAL AB | Health Technology |
| KAROLINSKA DEVELOPMENT AB | Finance |
| ANNEXIN PHARMACEUTICALS AB | Health Technology |
| Entreprise privées | 5 |
|---|---|
Lund University Bioscience AB
Lund University Bioscience AB Investment ManagersFinance Lund University Bioscience AB (LU Bio) is an investment firm located in Lund, Sweden. In May 2007, LU Bio was founded by the parent firm, Lund University Development AB. They specialize in early-stage investments within the life sciences segment. Lund University was founded by the Swedish government in 1666. The university has three main research areas: medicine and pharmaceuticals, globally sustainable societal development, and the life sciences. | Finance |
ProNoxis AB
ProNoxis AB Pharmaceuticals: MajorHealth Technology ProNoxis AB develops small-molecule drugs to treat chronic inflammation. The company was founded in 2009 and is headquartered in Lund, Sweden. | Health Technology |
Skogsmöllan AB
Skogsmöllan AB Pharmaceuticals: MajorHealth Technology Skogsmöllan AB is a private company based in Veberod, Sweden. The Swedish company provides pharmaceutical preparation services. | Health Technology |
Kongsberg Beam Technology AS
Kongsberg Beam Technology AS Miscellaneous Commercial ServicesCommercial Services Kongsberg Beam Technology AS develops and provides solutions for precise therapeutic radiation. The company was founded on August 2, 2005 and is headquartered in Kongsberg, Norway. | Commercial Services |
DermaGen AB
 DermaGen AB Pharmaceuticals: MajorHealth Technology DermaGen AB develops drugs and medical devices. It focuses on the development of topically applied products for the prevention and treatment of bacterial and fungal skin infections. The company was founded on February 2, 2004 and is headquartered in Solna, Sweden. | Health Technology |
